癌症研究中的金属:超越白金金属药物
Angela Casini1, Alexander Pöthig2
1Chair of Medicinal and Bioinorganic Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstraße 4, D-85748 Garching b. München, Germany.
ACS central science
|March 4, 2024
概括
有机金属化合物显示出作为抗癌金属药物的前景,提供独特的作用机制,并使向药物输送和癌细胞内的催化成为新的治疗策略.
科学领域:
- 药用无机化学 药用无机化学
- 有机金属化学 有机金属化学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 复合物历史上推动了抗癌金属药物的开发.
- 有机金属化合物在生理环境中提供了对反应性和稳定性的增强控制.
- 这些化合物促进了新型前药激活和基于非共价相互作用的疗法.
研究的目的:
- 探索有机金属化合物作为抗癌金属药物的潜力.
- 突出它们在前药激活和非共价药物向中的作用.
- 讨论它们在癌细胞内催化生物对等反应中的应用.
主要方法:
- 对有机金属抗癌剂的现有文献的审查.
- 分析涉及金属药物和"细胞催化剂"策略的案例研究.
- 讨论医用无机化学的挑战和机遇.
主要成果:
- 有机金属制品为设计金属药物提供了一个多功能平台,使用受控的MoA.
- 它们使得有效的前药激活和有针对性的输送系统成为可能.
- 它们的催化能力允许在癌细胞中进行选择性标记或信号放大.
结论:
- 有机金属化合物代表了抗癌金属药物开发的重大进步.
- 它们的独特特性促进了创新的治疗方法,包括有针对性的催化剂.
- 进一步研究药用无机化学对于实现其全部治疗潜力至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


